HERON THERAPEUTICS, INC. /DE/ (HRTX) › Net IncomeHERON THERAPEUTICS, INC. /DE/ (HRTX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2009: -$10.03M2010: -$7.35M2011: -$11.81M2012: -$23.35M2013: -$55.28M2014: -$76.37M2015: -$97.59M2016: -$173.14M2017: -$197.48M2018: -$178.84M2019: -$204.75M2020: -$227.28M2021: -$220.68M2022: -$182.02M2023: -$110.56M2024: -$13.58M2025: -$20.20M-$20.20M2009Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$20.20M-48.7%2024-$13.58M+87.7%2023-$110.56M+39.3%2022-$182.02M+17.5%2021-$220.68M+2.9%2020-$227.28M-11.0%2019-$204.75M-14.5%2018-$178.84M+9.4%2017-$197.48M-14.1%2016-$173.14M-77.4%2015-$97.59M-27.8%2014-$76.37M-38.1%2013-$55.28M-136.8%2012-$23.35M-97.6%2011-$11.81M-60.8%2010-$7.35M+26.7%2009-$10.03M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share